![New gene therapy approach may offer a new treatment for retinitis pigmentosa (RP) | UCL Institute of Ophthalmology - UCL – University College London New gene therapy approach may offer a new treatment for retinitis pigmentosa (RP) | UCL Institute of Ophthalmology - UCL – University College London](https://www.ucl.ac.uk/ioo/sites/ioo/files/capture.jpg)
New gene therapy approach may offer a new treatment for retinitis pigmentosa (RP) | UCL Institute of Ophthalmology - UCL – University College London
![Pharmaceutics | Free Full-Text | Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development Pharmaceutics | Free Full-Text | Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development](https://www.mdpi.com/pharmaceutics/pharmaceutics-15-00685/article_deploy/html/images/pharmaceutics-15-00685-g001.png)
Pharmaceutics | Free Full-Text | Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development
![Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR | Nature Medicine Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-020-0763-1/MediaObjects/41591_2020_763_Fig1_HTML.png)